Profiles of HCV core protein and viremia in chronic hepatitis C: Possible protective role of core antigen in liver damage

Journal of Medical Virology

Volumn 76, Issue 1, 2005, Pages 55-60

  Carabaich, Alessandro ^a   Ruvoletto, Mariagrazia ^a   Bernardinello, Elisabetta ^a   Tono, Natascia ^a   Cavalletto, Luisa ^a   Chemello, Liliana ^a   Gatta, Angelo ^a   Pontisso, Patrizia ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b Dip Medicina Clinica e Sperimentale   (Italy)

Author keywords

Density gradient analysis; Lipid associated HCV particles; Liver disease activity; Nucleocapsid particles

Indexed keywords

CORE PROTEIN; HEPATITIS C ANTIGEN; VIRUS RNA;

ADULT; AGED; ANTIVIRAL ACTIVITY; ARTICLE; BINDING KINETICS; BIOCHEMISTRY; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DENSITY GRADIENT; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOREACTIVITY; LIVER INJURY; LIVER PROTECTION; MAJOR CLINICAL STUDY; MALE; PHYSICAL CHEMISTRY; PROTEIN ANALYSIS; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; VIREMIA; VIRUS GENE; VIRUS MORPHOLOGY; VIRUS NUCLEOCAPSID;

ADULT; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; CARRIER STATE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEPACIVIRUS; HEPATITIS C ANTIGENS; HEPATITIS C, CHRONIC; HUMANS; LIPOPROTEINS; LIVER; MALE; MIDDLE AGED; RNA, VIRAL;

HEPATITIS C VIRUS;

EID: 15944382998     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20322     Document Type: Article

References (21)

1. André P, Komurian-Pradel F, Deforges S, Perret M, Berland JL, Sodoyer M, Pol S, Brechot C, Paranhos-Baccalà G, Lotteau V. 2002. Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J Virol 76:6919-6928.
2. Aoyagi K, Ohue C, Iida K, Kimura T, Tanaka E, Kiyosawa K, Yagi S. 1999. Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen. J Clin Microbiol 37:1802-1808.
3. Bouvier-Alias M, Patel K, Beaucourt S, Larderie P, Blatt L, Hezode C, Dhumeaux D, Neumann AU, McHutchison JG, Pawlotsky JM. 2002. Clinical utility of total HCV core antigen quantification: A new indirect marker of HCV replication. Hepatology 36:211-218.
4. Donadel E, Pontisso P, Ruvoletto MG, Gerotto M, De Salvo GL, Chemello L, Casarin C, Alberti A. 1998. Characteristics of hepatitis C virus before and after interferon treatment in patients with ongoing viraemia but sustained biochemical response. J Med Virol 54:7-11.
5. Feray C, Berthillon P, Ducolombier D, Maynard M, Codes L, Gigou M, Bizollon T, Samuel D, Trepo C. 2003. The HCV core Ag/HCV RNA ratio predicts the course of HCV replication in treated and untreated liver transplanted patients. Hepatology 38:468A.
6. Gerotto M, Dal Pero F, Pontisso P, Noventa F, Gatta A, Alberti A. 2000. Two PKR inhibitors HCV proteins correlate with early but not sustained response to interferon. Gastroenterology 119:1649-1655.
7. Jorgensen PA, Neuwald PD. 2001. Standardized hepatitis C virus RNA panels for nucleic acid testing assays. J Clin Virol 20:35-40.
8. Large MK, Kittlesen DJ, Hahn YS. 1999. Suppression of host immune response by the core protein of hepatitis C virus: Possible implication for hepatitis C virus persistence. J Immunol 9:1215-1219.
9. Maillard P, Krawczynski K, Nitkiewic J, Bronnert C, Sidorkiewicz M, Gounon P, Dubuisson J, Fauré G, Crainic R, Budkowksa A. 2001. Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients. J Virol 75:8240-8250.
10. Masalova OV, Atanadze SN, Samokhvalov EI, Petrakova NV, Kalinina TI, Smirnov VD, Khuyakov YE, Fild HA, Kushch AA. 1998. Detection of hepatitis C virus core protein circulating within different virus particle population. J Med Virol 55:1-6.
11. Maynard M, Pradat P, Picchio G, Voirin N, Martinet M, Marcellin P, Trepo C. 2003. Clinical relevance of total HCV core antigen testing for hepatitis C monitoring and for predicting patients' response to therapy. J Viral Hepat 10:318-323.
12. Monazahian M, Kippenberger S, Muller A, Seitz H, Bome I, Grethe S, Thomssen R. 2000. Binding of human lipoproteine (low, very low, high density lipoproteins) to recombinant envelope proteins of hepatitis C virus. Med Microbiol Immunol 188:177-184.
13. Pawlotsky JM. 2002. Use and interpretation of virological tests for hepatitis C. Hepatology 36:S65-S73.
14. Pontisso P, Bellati G, Brunetto M, Chemello L, Colloredo G, Di Stefano R, Nicoletti M, Rumi MG, Ruvoletto MG, Soffredini R, Valenza LM, Colucci G. 1999. Hepatitis C virus RNA profiles in chronically infected individuals: do they relate to disease activity? Hepatology 29:585-589.
15. Prince AM, Huima-Byron T, Parker TS, Levine DM. 1996. Visualization of hepatitis C virions and putative defective interfering particles isolated from low density lipoproteins. J Viral Hepat 3: 11-17.
16. Ray BR, Ray R. 2001. Hepatitis C virus core protein: intriguing properties and functional relevance. FEMS Microbiol Lett 202: 149-156.
17. Rebucci C, Cerino A, Cividini A, Timo L, Furione M, Mondelli MU. 2003. Monitoring response to antiviral therapy for patients with chronic hepatitis C virus infection by a core-antigen assay. J Clin Microbiol 41:3881-3884.
18. Thomssen R, Bonk S, Propfe C, Heermann KH, Kochel HG, Uy A. 1992. Association of hepatitis C virus in human sera with beta-lipoprotein. Med Microbiol Immunol 181:293-300.
19. Veillon P, Payan C, Picchio G, Maniez-Montreuil M, Guntz P, Lunel F. 2003. Comparative evaluation of the total hepatitis C virus core antigen, branched-DNA, and amplicor monitor assays in determining viremia for patients with chronic hepatitis C during interferon plus ribavirin combination therapy. J Clin Microbiol 41:3212-3220.
20. Yao ZQ, Eisen-Vandervelde A, Ray S, Hahn YS. 2003. HCV core/gCqR interaction arrests T cell cycle progression through stabilization of the cell cycle inhibitor p27/Kip1. Virology 314:271-282.
21. Zanetti AR, Romanò L, Brunetto M, Colombo M, Bellati G, Tackney C. 2003. Total HCV core antigen assay: A new marker of hepatitis C viremia for monitoring the progress of therapy. J Med Virol 70: 27-30.